YPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 12.7 EUR Market Closed

Market Cap: €22.8B

A	Astellas Pharma Inc DUS:YPH	JP
V	Valoe Oyj F:7RT	FI
	Shibaura Mechatronics Corp OTC:SHICF	JP
	Tatva Chintan Pharma Chem Ltd BSE:543321	IN
J	John Bean Technologies Corp F:JBT	US
B	Bank Pan Indonesia Tbk PT SWB:PTQ	ID
	Amte Power PLC F:9FO	UK
	BIGG Digital Assets Inc OTC:BBKCD	CA
M	Micronics Japan Co Ltd F:MJ3	JP
	Redwoods Acquisition Corp NASDAQ:WENA	US
D	Daphne International Holdings Ltd XMUN:PSX	CN

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

13% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.